10-Q · July 29, 2026
Clarivate’s Q2 revenue declined 5.5% year over year to $587.3M, with all segments lower and transactional revenue down 30.1%. Cost discipline lifted gross margin to 68.4% and adjusted EBITDA margin held at 42.1%, but a…
10-Q · Filed November 3, 2026 · Our reading of the company's report
The latest report
Clarivate delivered an adjusted EPS beat at $0.21 versus the $0.17 consensus estimate, but continuing-operations revenue of $481.6 million missed the $508.638 million estimate. GAAP results remained pressured by a $62.2…
Clarivate delivered an adjusted EPS beat at $0.21 versus the $0.17 consensus estimate, but continuing-operations revenue of $481.6 million missed the $508.638 million estimate. GAAP results remained pressured by a $62.2 million goodwill impairment, producing diluted EPS of $(0.13). Management issued 2026 targets of $1.965-$1.985 billion in revenue, $0.73-$0.77 of adjusted EPS, and $320-$340 million of free cash flow, but the direction versus its previous outlook cannot be determined.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Adjusted diluted EPS was $0.21, above the $0.17 consensus estimate, despite reported continuing-operations revenue of $481.6 million.
Management provided a 2026 outlook of $1.965-$1.985 billion of revenue and $0.73-$0.77 of adjusted diluted EPS, with free cash flow expected at $320-$340 million.
Disclosure controls were assessed as effective as of September 30, 2026, and management reported no changes during the quarter that materially affected internal control over financial reporting.
A $62.2 million goodwill impairment contributed to a reported diluted EPS loss of $(0.13), indicating continued GAAP earnings pressure despite the $0.21 adjusted EPS result.
Continuing-operations revenue of $481.6 million was below the $508.638 million consensus estimate, a shortfall of approximately $27.0 million.
The filing reports no material changes to prior risk factors, but a trading plan permits the sale of up to 254,558 ordinary shares by the President of Academia & Government through December 7, 2026.
A director resignation is effective December 31, 2026. The director stated that the resignation was not due to disagreement with the company, management, board, or any committee.
Updated 2026 outlook excludes discontinued operations and calls for revenue of $1.965-$1.985 billion, adjusted diluted EPS of $0.73-$0.77, and free cash flow of $320-$340 million. The filing/release does not provide enough prior-outlook detail to determine whether the outlook was raised or lowered.
Clarivate’s Q2 revenue declined 5.5% year over year to $587.3M, with all segments lower and transactional revenue down 30.1%. Cost discipline lifted gross margin to 68.4% and adjusted EBITDA margin held at 42.1%, but a…
Clarivate's Q1 2026 results showed a slight revenue decline of 1.4% year-over-year, totaling $585.5 million, while net losses improved to $40.2 million from $103.9 million in the prior year. Despite ongoing…
Clarivate positions itself as a leading provider of AI-enabled, subscription and re-occurring intelligence solutions across Academia & Government, Intellectual Property, and Life Sciences & Healthcare, serving more than…
Clarivate reported revenue of $621.4M for Q2 (June 30, 2025), a sequential increase from ~$594.0M but down vs. Q2 2024. Operating performance improved materially — income from operations was $6.9M vs an operating loss…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.
The free pages stop at the last full session. Trader shows every trade as it prints.